Mca-PLAQAV-Dpa-RSSSR-NH2 (TFA)

CAT:
804-HY-P3722A-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Mca-PLAQAV-Dpa-RSSSR-NH2 (TFA) - image 1

Mca-PLAQAV-Dpa-RSSSR-NH2 (TFA)

  • UNSPSC Description:

    Mca-PLAQAV-Dpa-RSSSR-NH2 is a fluorescent peptide and as one of fluorescent substrates of TNF-α converting enzyme (TACE): ADAM17, ADAM 9 and ADAM 10. Mca-PLAQAV-Dpa-RSSSR-NH2 is a substrate based on fluorescence resonance energy transfer, and its activity can be determined by the change of fluorescence intensity during pyrolysis[1].
  • Target Antigen:

    Fluorescent Dye; MMP
  • Type:

    Peptides
  • Related Pathways:

    Metabolic Enzyme/Protease;Others
  • Field of Research:

    Others
  • Assay Protocol:

    https://www.medchemexpress.com/mca-endo-1a-dap-dnp-tnf-alpha-5-to-6-amide-human-tfa.html
  • Purity:

    99.21
  • Solubility:

    H2O : 12.5 mg/mL (ultrasonic)
  • Smiles:

    O=C(N1[C@@H](CCC1)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@H](C(N)=O)CCCNC(N)=N)=O)=O)=O)=O)=O)CNC2=C(C=C(C=C2)[N+]([O-])=O)[N+]([O-])=O)=O)=O)=O)=O)=O)=O)CC(C3=CC=C(OC)C=C3O4)=CC4=O.OC(C(F)(F)F)=O
  • Molecular Weight:

    1752.72
  • References & Citations:

    [1]Yi Wang, et al. Protease assay method using site-specific fluorescence dye labeled protein as substrate. US9708638. 2017. |[2]Haga S, et al. TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds. Antiviral Res. 2010 Mar;85(3):551-5. |[3]Inoshima N, et al. Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection. J Invest Dermatol. 2012 May;132(5):1513-6. |[4]Liang T, et al. KID24, an antibody directed against ADAM9, is a potent inhibitor of tumor growth in vivo[J]. Molecular Cancer Therapeutics, 2007, 6(11_Supplement): C32-C32.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
  • Clinical Information:

    No Development Reported